References
- 1. WHO - Obesity and overweight. Fact sheet Nr. 311, Updated March 2011.
- 2. Feller S, Boeing H, Tobias Pischon T. Body Mass Index, Waist Circumference, and the Risk of Type 2 Diabetes Mellitus. Dtsch Arztebl Int. 2010. 107(26):470–476.10.3238/arztebl.2010.0470
- 3. vanDis I, Kromhout D, Geleijnse JM, Boer JM, Verschuren WM - BMI and WC predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years. Eur J Cardiovasc Prev Rehabil, 2009, 16(6):729-734.10.1097/HJR.0b013e328331dfc0
- 4. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med, 2008, 359:2105–2120.
- 5. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008;117:1658–1666.10.1161/CIRCULATIONAHA.107.739714
- 6. American Heart Association febr. 2011 - Heart and stroke facts. Dallas; 2011.
- 7. U.S. Depart of Health and Human Services NIH 2009. Weight-control Information Network. Physical Activity Guidelines for Americans. Oct. 2008. Available at http://www.health.gov/paguidelines.
- 8. Centers for Disease Control and Prevention. Youth Risk Behavior Surveillance United States, Morbidity & Mortality Weekly Report, 2008;57:SS-4.
- 9. Ryan Donna, David M Kendall, John Blundell, Ken Fujioka. Strategies to Combat Obesity: The Role of Appetite. Regulation and Impulse Control Authors and Disclosures. 2011 January 28.
- 10. Bogle Vanessa. Haringey Obesity Strategy. 2007-2010.
- 11. Tsigosa C, H Vojtech, Basdevant A, Finer N, Fried M, Mathus-Vliegen Elisabeth et al. Management of Obesity in Adults: European Clinical Practice Guidelines. The European Journal of Obesity. 2008;1(2):106–116.10.1159/000126822
- 12. Abell TL, Minocha A. Gastrointestinal complications of bariatric surgery: diagnosis and therapy. Am J Med Sci. 2006;331(4):214–218.10.1097/00000441-200604000-00008
- 13. Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet. 2010;375:1737-1748.10.1016/S0140-6736(10)60171-7
- 14. Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA. 1999;282(16):1530–1538.10.1001/jama.282.16.153010546692
- 15. Barness LA, Opitz JM, Gilbert-Barness E. Obesity: genetic, molecular, and environmental aspects. Am J Med Genet. 2007;143A(24): 3016–3034.10.1002/ajmg.a.3203518000969
- 16. Calle EE, Thun MJ, Petrelli JM, Rodriguez C. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341(15):1097–1105.10.1056/NEJM19991007341150110511607
- 17. Fried M, Hainer V, Basdevant A, et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (London). 2007;31(4):569–577.10.1038/sj.ijo.080356017325689
- 18. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, et al. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann Intern Med. 2003;138(1):24–32.10.7326/0003-4819-138-1-200301070-00008
- 19. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–1096.10.1016/S0140-6736(09)60318-4
- 20. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 2009; 28(5):822-831.10.1377/hlthaff.28.5.w822
- 21. Hammond RA. The economic impact of obesity in the US. Brookings Institute. Sept 2010.10.2147/DMSOTT.S7384
- 22. Heber D. An Integrative View of Obesity. Am J Clin Nutr. 2010;9:280S-283S.10.3945/ajcn.2009.28473B
- 23. National Institutes of Health, The Practical Guide Identification, Evaluation and Treatment of Overweight and Obesity in Adults National Heart, Lung, and Blood Institute NIH Publication No. 00-4084 October U.S. Department of Health and Human Services, 2000.
- 24. Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–1209.10.1016/S0140-6736(05)67483-1
- 25. Darvall KA, Sam RC, Silverman SH, Bradbury AW, Adam DJ. Obesity and thrombosis. Eur J Vasc Endovasc Surg. 2007;33(2):223–233.10.1016/j.ejvs.2006.10.00617185009
- 26. Lee SD, Ju G, Choi JA, Kim JW, Yoon IY. The association of oxidative stress with central obesity in obstructive sleep apnea. Sleep Breath. 2011 May 26.10.1007/s11325-011-0536-721614576
- 27. James WP. The fundamental drivers of the obesity epidemic. Obes Rev. 2008;S1:6-13.10.1111/j.1467-789X.2007.00432.x18307693
- 28. Katsuki A, Sumida Y, Gabazza EC, et al. Plasma levels of agouti-related protein are increased in obese men. J Clin Endocrinol Metab. 2001;86:1921.10.1210/jcem.86.5.745811344185
- 29. Vassallo Josanne. Pathogenesis of obesity. Journal of the Malta College of Pharmacy Practice. 2007;12:19–22.
- 30. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;341:879.10.1056/NEJM199909163411204
- 31. Bouchard C. Defining the genetic architecture of the predisposition to obesity: a challenging but not insurmountable task. Am J Clin Nutr. 2010;(91):5-6.10.3945/ajcn.2009.28933
- 32. Heather A. Genetic Predisposition to Type 2 Diabetes Promotes Weight Gain. Garvan Institute of Medical Research http://www.eurekalert.org/pub_releases/2010-05/ra-wgw051010.php.
- 33. Gardner DS, Hosking J, Metcalf BS, Jeffery AN, Voss LD, Wilkin T.J. Contribution of early weight gain to childhood overweight and metabolic health: a longitudinal study (Early Bird 36). Pediatrics, 2009;123(1):e67-73.10.1542/peds.2008-1292
- 34. Wang Gene-Jack, Nora D. Volkow, Joanna S. Fowler. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opinion on Therapeutic Targets. 2002;6:601-609.10.1517/14728222.6.5.601
- 35. Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2010;31:737-746.10.1093/eurheartj/ehp487
- 36. Kokkoris P, Pi-Sunyer FX. Obesity and endocrine disease. Endocrinol Metab Clin North Am. 2003;32:895-914.10.1016/S0889-8529(03)00078-1
- 37. Dietary Guidelines for Americans - U.S. Government Printing. Dietary Guidelines. gov/2010;
- 38. National Institute for Health and Clinical Excellence (NICE), (2006 and 2009) - Obesity: The prevention, identification, assessment and management of overweight and obesity in adults and children. London: NICE. www.nice.org.uk/guidance/CG43;
- 39. Wing Rena R, Phelan Suzanne. Science-Based Solutions to Obesity. Am J Clin Nutr. 2005;82(1 Suppl):207S–273S.10.1093/ajcn/82.1.207S16002821
- 40. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of Type 2 diabetes by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.10.1056/NEJM20010503344180111333990
- 41. Wadden TA, Sternberg JA, Letizia KA, Stunkard AJ. Treatment of obesity by very low calorie diet, behaviour therapy and combination: a 5 year experience. Int J Obes. 1989;13S:39-46.
- 42. Dixon JB, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–323.10.1001/jama.299.3.31618212316
- 43. Freitas A, Sweeney JF. Bariatric Surgery. In: B. Banerjee. Nutritional Management of Digestive Disorders. Boca Raton, FL: CRC Press. 2010;327–342.
- 44. Shikora SA, Kim J, Tarnoff ME. Nutritional and gastrointestinal complications of bariatric surgery. Nutrition in Clinical Practice. 2007;22(1):29–40.10.1177/01154265070220012917242452
- 45. Sjostrom L, et al - Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–752.10.1056/NEJMoa06625417715408
- 46. Thaler JP, Cummings DE - Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150:2518–2525.10.1210/en.2009-036719372197
- 47. Cummings DE. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (London). 2009;33(suppl1):S33–S40.10.1038/ijo.2009.1519363506
- 48. Neff LM, Kushner RF. Emerging role of GLP-1 rec. agonists in the treatment of obesity. Diabetes Metab Syndr Obes. 2010;3:263–273.10.2147/DMSO.S6816